Lobbying Information
Subject Matters
- Budget
- Economic Development
- Environment
- Health
- Industry
- International Trade
- Labour
- Regional Development
- Research and Development
- Science and Technology
- Taxation and Finance
Subject Matter Details
Legislative Proposal, Bill or Resolution
- Legislative and regulatory initiatives under the Canadian Environmental Protection Act (CEPA) relating to animate products of biotechnology and rules allowing for exception from notification and assessment requirements, specifically, Schedule 4 of CEPA.
- Regulatory initiatives related to the Human Pathogens and Toxins Act (HPTA), specifically, Schedules 1-5 of the HPTA.
Legislative Proposal, Bill or Resolution, Policies or Program
- Canada's Food and Consumer Safety Action Plan, specifically proposed legislation and regulation with respect to therapeutic products
Legislative Proposal, Bill or Resolution, Regulation
- Food and Drugs Act, specifically with respect to the authorization, regulation and life-cycle management of therapeutic products
Policies or Program
- Atlantic Growth Strategy, specifically initiatives related to skilled workforce/immigration, innovation, clean growth and climate change, trade and investment and infrastructure, and federal opportunities to invest in BioVectra facilities, operations and personnel in Atlantic Canada.
- Innovation Agenda and Science and Technology Strategy led by Innovation, Science and Economic Development, particularly with respect to the life sciences priority under the S&T Strategy
- Innovation, Science and Economic Development Canada Advantage Canada and Science and Technology Strategies, or other Government policy or program initiatives to support research and development, and manufacturing activities in Canada.
Regulation
- Food and Drugs Act Regulations, specifically with respect to the authorization, regulation and life-cycle management of therapeutic products
Communication Techniques
-
Written communication
-
Oral communication
The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.
Government Institutions
-
Atlantic Canada Opportunities Agency (ACOA)
-
Canada Foundation for Innovation
-
Canadian Environmental Assessment Agency (CEAA)
-
Employment and Social Development Canada (ESDC)
-
Environment and Climate Change Canada (ECCC)
-
Global Affairs Canada (GAC)
-
Health Canada (HC)
-
House of Commons
-
Innovation, Science and Economic Development Canada (ISED)
-
Prime Minister's Office (PMO)
Government institutions added through a monthly communication report
Client Details
Government funding
End date of the last completed financial year:
2015-09-25
List of Government Funding
|
Government Institution
|
Funding Received in Last Financial Year
|
Funding Expected in Current Financial Year
|
|
Atlantic Canada Opportunities Agency (ACOA)
|
$1,000,000.00
|
Yes
|
Client Contact Information
Address:
11 Aviation Avenue
Charlottetown, PE C1E 0A1
Canada
Telephone number:
902-566-9116
Client representative
Oliver Technow, President
Parent Company Information
- Mallinckrodt Pharmaceuticals
-
Perth House, Millennium Way Chesterfield
Derbyshire S418ND
United Kingdom
Coalition Members Information
BioVectra Inc. is not a coalition.
Individual, organization or corporation with a Direct Interest Beneficiary Information
The activities of BioVectra Inc. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Subsidiary Beneficiary Information
BioVectra Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyist Details
WILLIAM DEMPSTER
|
Public offices held
Business address:
130 Albert St.
Suite 408
OTTAWA, ON K1P 5G4
Canada
Telephone number:
613-614-0283
Fax number:
613-249-3645
Consultant Firm and Address
Firm:
3Sixty Public Affairs Inc. / 3Sixty Public Affairs Inc.
Address:
130 Albert Street
Suite 408
Ottawa, ON K1P 5G4
Canada
Telephone number:
613-800-8340
Fax number:
613-800-8343
